Bench to C-Suite — Data Governance in Life Sciences Organisations

Why Life Sciences Data Governance Fails

The primary failure mode is organisational, not technical. Data governance initiatives in Life Sciences typically begin in IT — driven by a platform migration, a regulatory observation, or an analytics ambition. They are staffed with data engineers and governed by IT steering committees.

The problem is that the people who create, use, and depend on the data — laboratory scientists, quality managers, regulatory affairs professionals, commercial leaders — are consulted but not embedded. They attend workshops, provide requirements, and review outputs. But they do not own the governance framework.

The result is a technically sound data architecture that does not reflect how data actually flows through the organisation. Master data definitions that make sense in an ERP context but do not match how scientists categorise samples. Data quality rules that pass automated checks but miss the contextual errors that a laboratory manager would catch immediately.

Effective data governance in Life Sciences requires dual ownership: IT owns the infrastructure and tooling, but the business owns the definitions, the quality standards, and the governance decisions.

Connecting Bench-Level Integrity to Executive Decisions

The data that reaches the boardroom — batch release rates, quality metrics, supply chain performance, regulatory submission timelines — originates at the laboratory bench. Every executive dashboard is only as reliable as the data entered by a laboratory scientist at 7am on a Monday morning.

This connection is rarely made explicit. Executive reporting is treated as a separate domain from laboratory data management. Different teams, different systems, different governance models. The result is a gap that only becomes visible when an executive decision is challenged — when a batch release metric does not reconcile with laboratory records, when a regulatory submission contains data that cannot be traced to its source.

Closing this gap requires data lineage — not as a theoretical concept, but as an operational capability. Every data point that reaches an executive dashboard should be traceable, through documented and automated pathways, back to its point of origin. The technology to do this exists. What is usually missing is the organisational commitment to build and maintain the lineage.

A Practical Framework for Life Sciences Data Governance

Based on our delivery experience across multiple Life Sciences organisations, we recommend a three-layer governance framework:

Layer 1 — Data Integrity at Source: Focus first on the systems where data is created — LIMS, ERP, MES, instrument data systems. Ensure ALCOA+ compliance (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available). This is not a new concept, but it is frequently under-implemented.

Layer 2 — Data Integration and Lineage: Map every data flow between systems. Document transformation rules. Implement automated reconciliation at integration boundaries. This layer is where most organisations have the largest gaps — data moves between systems through manual exports, spreadsheet transformations, and undocumented processes.

Layer 3 — Decision-Grade Analytics: Build executive reporting and analytics on top of governed, traceable data. Every metric should have a documented data source, transformation logic, and refresh frequency. When a board member asks "where does this number come from?" the answer should be immediate and complete.

Implementation should be incremental — start with the highest-risk data domains (typically batch release and regulatory submission data), demonstrate value, then expand. Attempting to govern all data simultaneously is the fastest path to governance fatigue and programme failure.